Relevant bibliographies by topics / The pharmaceutical enterprise

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'The pharmaceutical enterprise'

Author: Grafiati
Published: 30 May 2022
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'The pharmaceutical enterprise.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "The pharmaceutical enterprise"

1

Shabelnyk, Tetiana V. "The Method of Hierarchy Analysis as a Mechanism for Choosing a Development Strategy for a Pharmaceutical Enterprise." Business Inform 9, no. 548 (2023): 117–22. http://dx.doi.org/10.32983/2222-4459-2023-9-117-122.

Full text
Abstract:
The aim of the publication is to develop a method of hierarchy analysis for choosing the optimal market strategy for the development of a pharmaceutical enterprise. The article substantiates the need for continuous improvement of the decision support system of a pharmaceutical enterprise, which operates in conditions of constant changes in the external environment, to ensure the processes of continuous and stable growth of the enterprise. The main components of the external destabilizing factors of the modern pharmaceutical market, which require the introduction of special mechanisms for ensur
APA, Harvard, Vancouver, ISO, and other styles
2

Wedha, Bayu Yas, Michael Sagar Vasandani, and Alessandro Enriqco Putra Bayu Wedha. "Innovative Role of Blockchain Pharmaceutical Supply Chain Digital Transformation: Enterprise Architecture Perspective." sinkron 8, no. 4 (2023): 2490–500. http://dx.doi.org/10.33395/sinkron.v8i4.13043.

Full text
Abstract:
The advent of the Fourth Industrial Revolution has compelled numerous industries to undergo digital changes or transformations. One example is the pharmaceutical industry, which is responsible for providing medicinal products. The pharmaceutical supply chain assumes a crucial position within the pharmaceutical industry as it enables the secure, streamlined, and dependable transportation of medications from producers to individuals in need. The issue of prioritizing digital transformation within the pharmaceutical supply chain has emerged as a significant problem for hospitals and pharmaceutica
APA, Harvard, Vancouver, ISO, and other styles
3

Li, Jian Jun. "The Empirical Analysis of Small and Medium Sized Pharmaceutical Enterprises Operating Performance and Debt Source Structure." Applied Mechanics and Materials 496-500 (January 2014): 2872–75. http://dx.doi.org/10.4028/www.scientific.net/amm.496-500.2872.

Full text
Abstract:
in this paper, take 30 enterprises from Shenzhen SME board and the GEM pharmaceutical industry as samples, using empirical methods to study the relationship between the pharmaceutical industry and business performance and debt source structure. The results showed that small and medium-sized pharmaceutical enterprises have a negative impact on business performance, and operating liabilities have a positive impact on business performance; compared with the small service enterprises, performance of small and medium-sized pharmaceutical enterprise is poor, because its operating liabilities rate is
APA, Harvard, Vancouver, ISO, and other styles
4

Lisna, Anastasiіа, Olga Posilkina, Elena Litvinova, Yuliia Bratishko, and Olga Gladkova. "Methodological approaches to assessing digital maturity of logistics activities of pharmaceutical enterprises." ScienceRise: Pharmaceutical Science, no. 4(44) (August 31, 2023): 76–88. http://dx.doi.org/10.15587/2519-4852.2023.286741.

Full text
Abstract:
The aim: development of methodological approaches to assessing the digital maturity of the logistics activity of a pharmaceutical enterprise and elaboration of the proposed methodology on the example of those domestic enterprises that have a developed logistics system and some experience in the implementation of digital technologies in logistics activities.
 Materials and methods: Research was conducted using databases on the Internet: the European Center for Information Systems Research, the European Medicines Agency, and scientific and metric databases - Scopus, Web of Science. Logical,
APA, Harvard, Vancouver, ISO, and other styles
5

Cavalla, David. "The extended pharmaceutical enterprise." Drug Discovery Today 8, no. 6 (2003): 267–74. http://dx.doi.org/10.1016/s1359-6446(03)02634-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Cai, Yating. "Comparison of R&D information disclosure of Chinese and foreign listed pharmaceutical enterprises – Take Hengrui Pharmaceutical and Pfizer Pharmaceutical as examples." SHS Web of Conferences 170 (2023): 02021. http://dx.doi.org/10.1051/shsconf/202317002021.

Full text
Abstract:
Recently, the demand for epidemic prevention equipment and therapeutic drugs at home and abroad has surged. In order to improve their competitiveness, enterprises have invested a lot of money in drug research and development and medical device innovation.This paper focuses on the research and analysis of the background conditions of drug research and development and information disclosure in China in recent years, and combines and expounds two scientific theoretical foundations related to information disclosure and disclosure, namely information disclosure, asymmetry theory and information tra
APA, Harvard, Vancouver, ISO, and other styles
7

Demchenko, Nataliia V., Iryna A. Popova, Natalia Ye Lelyuk, and Alina B. Shved. "The Instruments and Ways to Ensure Economic Security of Pharmaceutical Enterprises." PROBLEMS OF ECONOMY 2, no. 56 (2023): 147–55. http://dx.doi.org/10.32983/2222-0712-2023-2-147-155.

Full text
Abstract:
The article identifies problems of ensuring economic security of enterprises of pharmaceutical industry of Ukraine. It is noted that the state of manufacturing pharmaceutical enterprises, complicated by military operations on the territory of Ukraine, requires the search for instruments to identify and forecast economic security as an effective task of crisis management of enterprises and stabilization of the functioning of the pharmaceutical industry. It is noted that ensuring the economic security of a manufacturing enterprise is considered as a complex system covering organizational-economi
APA, Harvard, Vancouver, ISO, and other styles
8

Huang, Zhe, Yipeng Lan, and Xiangqi Zha. "Research on government subsidy strategies for new drug R&D considering spillover effects." PLOS ONE 17, no. 2 (2022): e0262655. http://dx.doi.org/10.1371/journal.pone.0262655.

Full text
Abstract:
This paper studies the pharmaceutical production supply chain system composed of upstream and downstream pharmaceutical enterprises, and explores the impact of government subsidy strategies on the new drug research and development (R&D) decision variables and profits of pharmaceutical enterprises as well as social welfare, when considering both the horizontal spillover effects within the industry and the vertical spillover effects between industries. Comparing and analyzing the impact of these strategies including non-government subsidy strategy, pharmaceutical enterprise innovation input
APA, Harvard, Vancouver, ISO, and other styles
9

Lin, Chun Cai, and Yan Peng He. "Study on the Pharmaceutical Distribution Enterprise IT Adoption Influencing Factors Model." Applied Mechanics and Materials 548-549 (April 2014): 1947–53. http://dx.doi.org/10.4028/www.scientific.net/amm.548-549.1947.

Full text
Abstract:
With the national policy changes, pharmaceutical distribution companies using information technology to improve the competitiveness of enterprises was imperative. This paper took TAM and TOE as theoretical framework. And then combined pharmaceutical distribution business characteristics，the pharmaceutical distribution enterprise IT adoption influencing factors model was conducted with technical, organizational and environment organizational characteristics. The empirical results supported that relative advantages, compatibility, complexity, firm characteristic, leadership support, human resour
APA, Harvard, Vancouver, ISO, and other styles
10

Yang, Jingyuan, Ling Wang, Ziyuan Sun, Fangming Zhu, Yihui Guo, and Yan Shen. "Impact of Monetary Policy Uncertainty on R&D Investment Smoothing Behavior of Pharmaceutical Manufacturing Enterprises: Empirical Research Based on a Threshold Regression Model." International Journal of Environmental Research and Public Health 18, no. 21 (2021): 11560. http://dx.doi.org/10.3390/ijerph182111560.

Full text
Abstract:
R&D investment is the source of technological innovation of pharmaceutical enterprises, but it will be restricted by the funding level, especially in the context of major public health emergencies occurring more frequently, therefore exploring the impact of monetary policy uncertainty on the R&D investment smoothing behavior of pharmaceutical manufacturing enterprises has important theoretical and practical value. Based on the relevant data of Chinese pharmaceutical manufacturing enterprises from 2012 to 2018, this paper studies the impact of monetary policy uncertainty on R&D inve
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "The pharmaceutical enterprise"

1

Martins, André Oliveira. "Creating a business model for a pharmaceutical bank in Lisbon." Master's thesis, NSBE - UNL, 2013. http://hdl.handle.net/10362/9778.

Full text
Abstract:
A Work Project, presented as part of the requirements for the Award of a Masters Degree in Management from the NOVA – School of Business and Economics<br>The present Work Project highlights the problem of the market disequilibrium existing in the pharmaceutical industry, caused by the coexistence of both: overproduction (implied destruction costs), and the fact that many patients have insufficient purchase power. This Work Project develops a two-phase methodology to recognize best practices of social enterprises. The first phase is the elaboration of a questionnaire and the second is a one-on-
APA, Harvard, Vancouver, ISO, and other styles
2

Saskiewicz, Paul E. "The Revolutionary Armed Forces of Colombia - People's Army (FARC-EP) : Marxist-Leninist insurgency or criminal Enterprise? /." Thesis, Monterey, Calif. : Springfield, Va. : Naval Postgraduate School ; Available from National Technical Information Service, 2005. http://library.nps.navy.mil/uhtbin/hyperion/05Dec%5FSaskiewicz.pdf.

Full text
Abstract:
Thesis (M.A. in National Security Affairs)--Naval Postgraduate School, December 2005.<br>Thesis Advisor(s): Jeanne Giraldo, Douglas Porch. Includes bibliographical references (p. 119-130). Also available online.
APA, Harvard, Vancouver, ISO, and other styles
3

Govender, Inbanathan. "An analysis of the key drivers, decision making and strategic issues with respect to outsourcing in the SA pharmaceutical manufacturing industry." University of South Africa, 2007. http://hdl.handle.net/10500/59.

Full text
Abstract:
“Outsourcing has been touted as the ideal way for organisations to reduce cost, focus on core business processes, improve services, enhance skills, reduce time-to-market and increase overall competitive advantage,” (Power, Bonifazi and Desouza, 2004). A pertinent question is therefore ‘Can South African companies in the pharmaceutical industry remain competitive by outsourcing, what is driving these companies to outsource and how effective has the initiative been?’ The purpose of the study is to identify the extent to which various key factors play an influential role in motivating phar
APA, Harvard, Vancouver, ISO, and other styles
4

Луб’янова, Я. О. "Удосконалення системи управління сучасним підприємством (на прикладі ТОВ "Кусум Фарм")". Thesis, Сумський державний університет, 2017. http://essuir.sumdu.edu.ua/handle/123456789/64981.

Full text
Abstract:
Управління сучасним підприємством можна визначити як сукупність методів і засобів професійного керівництва над діяльністю відокремленої юридичної особи по досягненню цілей її роботи і отриманню прибутку на основі раціонального використання власних і залучених ресурсів. Стрімко змінювані зовнішні умови праці вітчизняних підприємств потребують адекватного розвитку механізму системи управління підприємством.
APA, Harvard, Vancouver, ISO, and other styles
5

Корж, В. М., та С. О. Суптельна. "ПАТ «Фармак» - провідник сучасних технологій". Thesis, Сумський державний університет, 2018. http://essuir.sumdu.edu.ua/handle/123456789/67682.

Full text
Abstract:
Метою роботи є дослідження розвитку ПАТ «Фармак» від радянського минулого до європейського майбутньогона території технопарку «Свема» з метою формування умов підвищення екологічної безпеки виробництв фармацевтичної галузі України.
APA, Harvard, Vancouver, ISO, and other styles
6

Gusberti, Tomoe Daniela Hamanaka. "Modelo de intervenção para processo de desenvolvimento de produto farmaceutico [sic] para pequenas e médias empresas." reponame:Biblioteca Digital de Teses e Dissertações da UFRGS, 2006. http://hdl.handle.net/10183/8703.

Full text
Abstract:
Os administradores de pequenas e médias empresas (PME) buscam práticas de desenvolvimento de produtos e conhecimento que auxilie a permanência delas e o crescimento no mercado. Uma forma de incorporar práticas consagradas é através da sistematização do Processo de Desenvolvimento de Produto (PDP). A representação desse processo pode ser realizada por meio de modelos referenciais os quais incluem atividades, ferramentas, conceitos e melhores práticas. Apesar disso, no que se refere à estruturação do PDP, de um modo geral, as empresas não incorporaram facilmente essas práticas à sua realidade. E
APA, Harvard, Vancouver, ISO, and other styles
7

吳黎純. "中藥業的現代化 : 余仁生個案研究 = Modernization of traditional Chinese medicine enterprise : a case study of Eu Yan Sang". HKBU Institutional Repository, 2005. http://repository.hkbu.edu.hk/etd_ra/649.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

PATEL, SHARMILA, and MARIAM RABIZADEGAN. "Moving Toward Green Production Systems in the Pharmaceutical Industry : Implementing Artificial Intelligence to Increase Environmental Efforts in SMEs." Thesis, KTH, Skolan för industriell teknik och management (ITM), 2021. http://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-300124.

Full text
Abstract:
The pharmaceutical sector is important for human health due to the increasing demand for medical products but is also a pollution and waste intensive industry. There is an urgent need for the industry to review its environmental footprints and simultaneously consider the industrial transformation called Industry 4.0. This is especially true for small and medium sized enterprises (SMEs). To achieve these objectives, it is presumed that artificial intelligence (AI) will have an important role.  This thesis sets out to identify barriers that pharmaceutical SMEs may encounter when implementing AI
APA, Harvard, Vancouver, ISO, and other styles
9

Jiang, Fuming, and fuming jiang@anu edu au. "Foreign pharmaceutical firms' FDI entry strategies into China." Swinburne University of Technology, 2001. http://adt.lib.swin.edu.au./public/adt-VSWT20050407.095122.

Full text
Abstract:
Foreign direct investment (FDI) in China is popular these days and this also applies to the pharmaceutical manufacturing industry. China seems to be a promising market for pharmaceuticals with over 1.2 billion potential consumers. This huge number of people together with the outstanding economic performance attracted multinational pharmaceutical firms that were looking for a new market for their products. By the end of 1998, China had established over 1,500 pharmaceutical enterprises with foreign investment and 117 of which were invested by foreign pharmaceutical firms. Foreign pharmaceutical
APA, Harvard, Vancouver, ISO, and other styles
10

Lofgren, Hans. "Globalisation of the pharmaceutical industry and the Australian state : the transformation of a policy network /." Connect to thesis, 1997. http://eprints.unimelb.edu.au/archive/00000300.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "The pharmaceutical enterprise"

1

Markets, Swiss Re New, and Schweizerische Rückversicherungs-Gesellschaft, eds. Risk handling and financing in pharmaceutical enterprises. Swiss Reinsurance Company, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

South Carolina. Department of Commerce. Opportunities for pharmaceutical companies in South Carolina. South Carolina Department of Commerce, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Pazderka, Bohumir. Multinational R & D activity in the pharmaceutical industry. Commission of Inquiry on the Pharmaceutical Industry; Supply and Services Canada, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Pradhan, Jaya Prakash. Overseas acquisition versus greenfield foreign investment: Which Internationalization strategy is better for Indian pharmaceutical enterprises. Institute for Studies in Industrial Development, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Dalal Consultants and Engineers Limited (Ahmedabad, India). Management Consultancy Division. and MVIRDC World Trade Centre, Bombay., eds. Impact of liberalisation and globalisation on the small & medium enterprises in the bulk drug & dyes sectors. MVIRDC World Trade Centre, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Canada. Commission of Inquiry on the Pharmaceutical Industry. Multinational r&d activity in the pharmaceutical industry. Commission of Inquiry on the Pharmaceutical Industry, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Benseba, Djamel. Les firmes multinationales pharmaceutiques et les pays en voie de développement. Office des publications universitaires, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Tewes, Stefan. Internationalisierung der japanischen Pharmaindustrie: Strategien und Perspektiven Japans auf dem Weg zum Pharmaweltmarkt. S + W Steur- und Wirtschaftsverlag, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Singh, Satwinder. Multinational corporations and Indian drug industry. Criterion Publications, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Centro Interdisciplinario de Estudios sobre el Desarrollo Uruguay. Departamento de Asesoramiento Técnico, Económico y Social., ed. La Industria farmaceútica y las transnacionales. Departamento de Asesoramiento Técnico, Económico y Social, Centro Interdisciplinario de Estudios sobre el Desarrollo-Uruguay, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "The pharmaceutical enterprise"

1

Swarnkar, Rahul, Jennifer A. Harding, Bishnu P. Das, Robert I. Young, and S. Krishna Kumar. "Application of Collaboration Moderator Service in Pharmaceutical Industry: A Collaborative Drug Discovery Use Case." In Enterprise Interoperability V. Springer London, 2012. http://dx.doi.org/10.1007/978-1-4471-2819-9_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Kharchenko, Vyacheslav, Oleksandr Gordieiev, and Alina Fedoseeva. "Profiling of Software Requirements for the Pharmaceutical Enterprise Manufacturing Execution System." In Studies in Computational Intelligence. Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-19147-8_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Lan, Hongjie, and Zijun Yang. "Promoting Mechanisms of Logistic Capability of Pharmaceutical Wholesale Enterprise Based on Brusselator." In LISS 2013. Springer Berlin Heidelberg, 2013. http://dx.doi.org/10.1007/978-3-642-40660-7_35.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Miyake, Tetsuro, Yoshimasa Masuda, Katsura Deguchi, Masashi Iwasaki, Kazuya Obanayama, and Kasei Miura. "Strategic Risk Management Model for Agile Software Development: Case of Global Pharmaceutical Enterprise." In Innovation in Medicine and Healthcare. Springer Nature Singapore, 2022. http://dx.doi.org/10.1007/978-981-19-3440-7_24.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Maximova, Tatyana, Andrei S. Nikolaev, Valentina V. Ivashchenko, Anastasia V. Sennikova, and Aleksandra A. Cherkashina. "Effectiveness of Patinformatics Research for Building IP Management Strategy in a Pharmaceutical Enterprise." In Software Engineering Perspectives in Systems. Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-031-09070-7_21.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Cahill, Brian, Fabrizio Conicella, Eoin Galligan, and Miklós Györffi. "To Be or Not to Be: Entrepreneurship and Enterprise Creation as a Way to Innovate in Life Sciences." In Career Options in the Pharmaceutical and Biomedical Industry. Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-14911-5_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

MalikulMulki, Firas Arasy Dzikru, Yodi Nurdiansyah, and Prafajar Suksessanno Muttaqin. "Business Process Improvement and Information System Design in Procurement Process at Pharmaceutical Company." In Proceedings of the International Conference on Enterprise and Industrial Systems (ICOEINS 2023). Atlantis Press International BV, 2023. http://dx.doi.org/10.2991/978-94-6463-340-5_27.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Hartaniah, Siti Alifah, R. Wahjoe Witjakcono, and Muhardi Saputra. "Analysis of SAP Integration in Procurement Process Based on TOGAF (Case Study: Pharmaceutical Holding Company)." In Proceedings of the International Conference on Enterprise and Industrial Systems (ICOEINS 2023). Atlantis Press International BV, 2023. http://dx.doi.org/10.2991/978-94-6463-340-5_17.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Wisanggeni, Ario, R. Wahjoe Witjaksono, and Muhardi Saputra. "Analysis of Microsoft Dynamics AX Implementation Based on TOGAF For Pharmaceutical Holding Company: A Case Study." In Proceedings of the International Conference on Enterprise and Industrial Systems (ICOEINS 2023). Atlantis Press International BV, 2023. http://dx.doi.org/10.2991/978-94-6463-340-5_16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Balcet, Giovanni, and Silvia Bruschieri. "Acquisition of Technologies and Multinational Enterprise Growth in the Automotive and the Pharmaceutical Industries: Drivers and Strategies." In The Rise of Indian Multinationals. Palgrave Macmillan US, 2010. http://dx.doi.org/10.1057/9780230114753_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "The pharmaceutical enterprise"

1

Carlos, Humberto, Luciana Lee, and Mateus Costa. "Empowering Pharmaceutical Retail Storefronts: An Exploratory Study on Classification and Association Techniques." In 27th International Conference on Enterprise Information Systems. SCITEPRESS - Science and Technology Publications, 2025. https://doi.org/10.5220/0013429000003929.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Liang, Lijun, Litong Cui, Guoyu Chen, and Xindi Liang. "Tuning of Abnormal Financial Data Alarm Model for Pharmaceutical Enterprises–Fusion Based on PSO-RF Algorithm." In 2024 2nd International Conference on Computer Network Technology and Electronic and Information Engineering (CNTEIE). IEEE, 2024. https://doi.org/10.1109/cnteie66268.2024.00009.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Bhandigani, Rutuja, Nikhil Ujjwal, Shubham Pattekar, and Amit Sadanand Savyanavar. "Enterprise Optimization in Pharmaceutical Industry." In 2021 International Conference on Smart Generation Computing, Communication and Networking (SMART GENCON). IEEE, 2021. http://dx.doi.org/10.1109/smartgencon51891.2021.9645744.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Mitan, Electra. "WORKPLACE TRAINING APPROACH IN PHARMACEUTICAL ENTERPRISE MANAGEMENT." In 16th International Conference on Education and New Learning Technologies. IATED, 2024. http://dx.doi.org/10.21125/edulearn.2024.1887.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Fedoseeva, A., and V. Kharchenko. "Profiling of MES software requirements for the pharmaceutical enterprise." In 2014 East-West Design & Test Symposium (EWDTS). IEEE, 2014. http://dx.doi.org/10.1109/ewdts.2014.7027090.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

K. Buor, John, and Enock Selasi Darteh. "Leveraging Enterprise Resource Planning (ERP) Systems for Productivity Enhancement in Small-Medium Pharmaceutical Enterprises." In 7th European Conference on Industrial Engineering and Operations Management. IEOM Society International, 2024. http://dx.doi.org/10.46254/eu07.20240094.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Biazon de Oliveira, Maiza, Giorgio Zucchi, Marco Lippi, Douglas Cordeiro, Núbia Rosa da Silva, and Manuel Iori. "Lead Time Forecasting with Machine Learning Techniques for a Pharmaceutical Supply Chain." In 23rd International Conference on Enterprise Information Systems. SCITEPRESS - Science and Technology Publications, 2021. http://dx.doi.org/10.5220/0010434406340641.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

"DATA COMPLIANCE IN PHARMACEUTICAL INDUSTRY - Interoperability to Align Business and Information Systems." In 8th International Conference on Enterprise Information Systems. SciTePress - Science and and Technology Publications, 2006. http://dx.doi.org/10.5220/0002460300790086.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Deacon, J. "Can you validate enterprise systems such as SAP R/3?" In IEE Colloquium on Responsibilities and Practicalities for Testing Pharmaceutical Software. IEE, 1997. http://dx.doi.org/10.1049/ic:19970933.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Song, Tianqi, and Xiaoyi Chen. "Research on Enterprise Internal Control Risk Based on Kangmei Pharmaceutical Event." In ICMSS 2020: 2020 4th International Conference on Management Engineering, Software Engineering and Service Sciences. ACM, 2020. http://dx.doi.org/10.1145/3380625.3380629.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "The pharmaceutical enterprise"

1

Li, Richard. Challenges facing European pharmaceutical SMEs. LegalOne Global Limited, 2025. https://doi.org/10.62436/a-1741138780788.

Full text
Abstract:
The European pharmaceutical industry is a dynamic and vital sector, upheld by rigorous regulatory standards to ensure the safety and efficacy of medicinal products. Small to medium-sized enterprises (SMEs) play a crucial role in this landscape, driving innovation and contributing significantly to economic growth. However, these companies often face disproportionate challenges when navigating the complex regulatory and compliance environment. The substantial costs, resource demands, and expertise required to meet regulatory obligations can be burdensome, potentially hindering innovation and mar
APA, Harvard, Vancouver, ISO, and other styles
2

Collington, Rosie, and William Lazonick. Pricing for Medicine Innovation: A Regulatory Approach to Support Drug Development and Patient Access. Institute for New Economic Thinking Working Paper Series, 2022. http://dx.doi.org/10.36687/inetwp176.

Full text
Abstract:
The United States represents the world’s largest market for pharmaceutical drugs. It is also the only advanced economy in the world that does not regulate drug prices. There is no upper threshold for the prices of medicines in the United States. List prices are instead set by manufacturers in negotiation with supply-chain intermediaries, though some federal programs have degrees of discretion in price determinations. In practice, this deregulated system means that drug prices in the United States are generally far higher than in other advanced economies, adversely affecting patient accessibili
APA, Harvard, Vancouver, ISO, and other styles
3

PATENTS OF LARGE PHARMACEUTICAL ENTERPRISES IN THE FIELD OF NANOTECHNOLOGY. StatNano, 2014. http://dx.doi.org/10.22631/plpe.2014.09.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

The Golden Thread: Sector Report. Association for Project Management, 2019. http://dx.doi.org/10.61175/avoh7436.

Full text
Abstract:
In this report our attention turns to some of the sectors where project management skills are increasingly being utilised to run projects more effectively, efficiently and professionally. Although the project profession was originally established within the engineering and construction industries, today its reach spreads far wider, with many industry sectors reaping the benefits of effective project management techniques. This examination focuses on three growth areas for project management which APM believes deserve specific attention as sectors where the contribution of project management ha
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'The pharmaceutical enterprise' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography